These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22562075)

  • 21. Finding the right time for weaning off immunosuppression in solid organ transplant recipients.
    Orlando G
    Expert Rev Clin Immunol; 2010 Nov; 6(6):879-92. PubMed ID: 20979553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New strategies in immunosuppression.
    Regazzi MB; Alessiani M; Rinaldi M
    Transplant Proc; 2005; 37(6):2675-8. PubMed ID: 16182781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role and value of sirolimus administration in kidney and liver transplantation.
    Mehrabi A; Fonouni H; Kashfi A; Schmied BM; Morath Ch; Sadeghi M; Schemmer P; Encke J; Sauer P; Zeier M; Weitz J; Büchler MW; Schmidt J
    Clin Transplant; 2006; 20 Suppl 17():30-43. PubMed ID: 17100699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
    Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
    J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Post-transplantation malignant tumors and the challenges of immunosuppressive therapy in transplanted patients developing lymphoma. Mycophenolic acid as a possibility].
    Végso G
    Magy Onkol; 2009 Jun; 53(2):149-56. PubMed ID: 19581181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The new immunosuppressive era.
    Lo Monte AI; Ciancio G; Burke G; Roth D; Miller J
    Ann Ital Chir; 1999; 70(1):1-19. PubMed ID: 10367502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Report from the National Transplantation Pregnancy Registry: outcomes of pregnancy after transplantation.
    Armenti VT; Daller JA; Constantinescu S; Silva P; Radomski JS; Moritz MJ; Gaughan WJ; McGrory CH; Coscia LA
    Clin Transpl; 2006; ():57-70. PubMed ID: 18368705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New perspectives of immunosuppression.
    Halleck F; Friedersdorff F; Fuller TF; Matz M; Huber L; Dürr M; Schütz M; Budde K
    Transplant Proc; 2013 Apr; 45(3):1224-31. PubMed ID: 23622665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomarkers as a tool for management of immunosuppression in transplant patients.
    Wieland E; Olbricht CJ; Süsal C; Gurragchaa P; Böhler T; Israeli M; Sommerer C; Budde K; Hartmann B; Shipkova M; Oellerich M
    Ther Drug Monit; 2010 Oct; 32(5):560-72. PubMed ID: 20814352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological manipulation of the rejection response.
    Hopkins PM
    Methods Mol Biol; 2006; 333():375-400. PubMed ID: 16790860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kidney transplantation: the ideal immunosuppression regimen.
    Yabu JM; Vincenti F
    Adv Chronic Kidney Dis; 2009 Jul; 16(4):226-33. PubMed ID: 19576552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Operational tolerance: past lessons and future prospects.
    Levitsky J
    Liver Transpl; 2011 Mar; 17(3):222-32. PubMed ID: 21384504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conventional and novel approaches to immunosuppression.
    Floreth T; Bhorade SM; Ahya VN
    Clin Chest Med; 2011 Jun; 32(2):265-77. PubMed ID: 21511089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Low-toxicity immunosuppressive therapy in renal transplant].
    Scolari F; La Manna G; Comai G; Cappuccilli ML; Todeschini P; Ciavatti A; Persici E; Feliciangeli G; Stefoni S
    G Ital Nefrol; 2007; 24 Suppl 38():44-8. PubMed ID: 17922447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current topics in immunotherapy and the role of the pharmacist on a solid organ transplant service.
    Shaefer MS
    Pharmacotherapy; 1991; 11(6):136S-141S. PubMed ID: 1771138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for immunosuppression in lung transplantation.
    Hopkins PM; McNeil K
    Curr Opin Organ Transplant; 2008 Oct; 13(5):477-83. PubMed ID: 19060529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The beginning of clinical tolerance in solid organ allografts.
    Monaco AP
    Exp Clin Transplant; 2004 Jun; 2(1):153-61. PubMed ID: 15859922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defining the risks for cytomegalovirus infection and disease after solid organ transplantation.
    Stratta RJ; Pietrangeli C; Baillie GM
    Pharmacotherapy; 2010 Feb; 30(2):144-57. PubMed ID: 20099989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunosuppression trends in solid organ transplantation: The future of individualization, monitoring, and management.
    Pilch NA; Bowman LJ; Taber DJ
    Pharmacotherapy; 2021 Jan; 41(1):119-131. PubMed ID: 33131123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Modern immunosuppression after solid organ transplantation].
    Beimler J; Morath C; Zeier M
    Internist (Berl); 2014 Feb; 55(2):212-22. PubMed ID: 24518922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.